- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Radiofrequency Ablation and Myomectomy Both Improve Fibroid Symptoms and Quality of Life: Study

Researchers have found in a new study that Laparoscopic radiofrequency ablation (RFA) and myomectomy produced significant and sustained improvements in uterine fibroid symptoms and health-related quality of life over 2 years. Although myomectomy showed slight advantages, the differences were not clinically significant. RFA may be an option for women seeking symptom relief while preserving the possibility of vaginal childbirth. The study was published in the Obstetrics and Gynecology journal by Antoinette A. and colleagues.
A robust comparison of the patient reported outcomes between these two procedures was performed using the data collected in the ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) prospective cohort multicenter study carried out in both academic and community hospitals in the US.
The study included 401 pre-menopausal women (mean age 39.2 ± 6.9 years; 53% African American [n = 210]) with symptomatic uterine fibroids, and the patients opted for either laparoscopic RFA (n = 237) or myomectomy (n = 164). They were asked to complete validated questionnaires, such as the UFS-QOL (Uterine Fibroid Symptom and Health-related Quality of Life), at baseline and 6-month intervals up to 24 months after treatment. Propensity weighted repeated measures analysis was used to reduce potential biases.
Key findings:
- Propensity-weighted modeling across the 401 study participants provided detailed quantitative metrics regarding symptom relief and quality-of-life trajectories over the 24-month observation period.
- Among 401 enrolled women (237 RFA, 164 myomectomy), 386 provided follow-up measures; participants presented with a median of 2 leiomyomas (IQR 1–15) and severe baseline symptom burden (mean SSS score 61 ± 23; mean HRQOL score 41 ± 26).
- Both cohorts demonstrated marked improvement; myomectomy achieved a slightly greater reduction in Symptom Severity Scale (SSS) scores compared to RFA (−33.0 vs. −27.7; mean difference −5.27, P = 0.028).
- The myomectomy group demonstrated modestly greater improvements in overall HRQOL score compared to RFA (34.92 vs. 28.29; mean difference −6.62, P = 0.011).
- The statistical differences observed between treatments remained below the predefined clinical thresholds required for minimal clinically important changes (10 points for SSS and 20 points for HRQOL).
- Furthermore, while myomectomy showed minor early advantages at 6 months in functional domains like daily activities, personal control, and self-consciousness, these subtle differences diminished and were completely absent by 24 months.
In conclusion, laparoscopic RFA and myomectomy both result in considerable and lasting benefits in the management of symptoms associated with fibroids for two years. The findings in the study show that although myomectomy results in slight numerical increases in some subscales, the overall difference is too small to be clinically significant.
Reference:
Allen, A., Schembri, M., Parvataneni, R., Waetjen, L. E., Varon, S., Salamat-Saberi, N., Garza, H., Kho, K. A., Sobolewski, C. J., Hawkins, S., Williams, N., Tassone, S., & Jacoby, V. L. (2026). Effectiveness of Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy on Symptoms and Health-Related Quality of LifeObstetrics & Gynecology https://doi.org/10.1097/AOG.0000000000006432
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

